The protective equipment maker has closed a financial year it expected to meet or beat its targets, with healthy Demand for respiratory and head protection underpinning its outlook.
Avon Technologies (LSE:AVON), the maker of respiratory protection systems and military helmets, closed its financial year on 30 September, and investors are now looking ahead to its preliminary results, which the FTSE 250 company has typically published in November. There has been little fresh company-specific news in recent weeks, so attention rests on the momentum established in earlier updates and the supportive defence spending backdrop.
A healthy run of results
The company's most recent detailed full-year figures, for the year to September 2025, showed Revenue up 14% to $313.9 million and adjusted operating profit up 28% to $40.3 million. Pre-tax profit rose to $13.1 million from $2.3 million, and the closing order book increased 17% to $262.8 million, with orders in the Avon Protection segment up 63%. The board raised the full-year Dividend by 5.6% to 24.6 US cents. The shares rose more than 7% on the day those results were released.
At the time, management said it was firmly on track to meet or exceed its key targets for the 2026 financial year, including high single-digit revenue growth and an Operating Margin in a range of 14–16%. Chief executive Jos Sclater noted that adjusted Earnings Per Share had more than doubled since 2023.
First-half momentum
The group's interim results earlier in 2026 reinforced that picture, with Mr Sclater describing a healthy first half in which revenue, profit and margin were all up significantly. He characterised the Business as moving from stabilisation to growth, crediting operational improvements and increased capacity. Notable contract wins included a multi-year respiratory protection programme with the Canadian Armed Forces and a filter contract worth around $14 million from the US Department of Defense. A first-quarter update in January had also confirmed that guidance was being maintained, despite some slower activity in the US at the start of the year.
Two businesses, shared drivers
Avon operates through two main divisions. Avon Protection supplies gas masks, breathing apparatus and filters to military forces and first responders, and has benefited from heightened global demand for chemical, biological, radiological and nuclear (CBRN) protection. Team Wendy produces helmets and related head protection, where increased production has supported growth. Both are closely linked to government procurement budgets, particularly in the United States and Europe.
The broader backdrop has been favourable. NATO members have pledged to raise defence spending, and the war in Ukraine and instability in the Middle East have increased focus on soldier protection and preparedness. However, US defence budgets and contract timing can be unpredictable, and the company's earlier history included periods of operational difficulty, so execution remains an important consideration for investors. The company reports in US dollars, reflecting the importance of its American customers, which means movements in the dollar against sterling can also affect how its results translate for London-listed shareholders.
What to watch at the full-year results
When Avon reports its preliminary results, the key questions will be whether revenue growth and margins landed within or above the targeted ranges, how the order book has developed, and what guidance management provides for the 2027 financial year, for which it previously said it had outpaced its original revenue growth expectations. Any update on cash generation and the dividend will also be watched.




_11_18_2026_14_55_02_703826.jpg)

Please wait processing your request...